US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Respiratory/Pulmonary Market Research Reports & Industry Analysis

RSS Feeds

Respiratory/Pulmonary Industry Research & Market Reports

1    3    5  6  7  8  9  10  
Lung Cancer Drug Pathway Analyzer
2/1/2016 | published by: BioSeeker Group AB
... plethora of treatment strategies is based on our increasing understanding of the 381 drug targets that are included in this drug-pathway analyzing tool. No less than 369 of these have been recorded with mutations and ...  |  read more...
USD 6,750
Target Atlas in Lung Cancer: A Competitive Outlook
2/1/2016 | published by: BioSeeker Group AB
... Target Approaches in development today from your competitors and prospective partners and revealing the areas where your company can succeed. Target Atlas in Lung Cancer: A Competitive Outlook is a one-of-a-kind, authoritative target analyzer tool, ...  |  read more...
USD 6,750
Idiopathic pulmonary fibrosis (IPF) - Market Insights, Epidemiology and Market Size Forecast-2020
2/1/2016 | published by: DelveInsight
... (France, Germany, Italy, Spain, UK) and Japan. It also includes global historical and forecasted epidemiological data for the diagnosed incident cases of Idiopathic pulmonary fibrosis (IPF) from 2010-2020.Hemophilia is a bleeding disorder that slows the ...  |  read more...
USD 4,950
Respiratory syncytial virus (RSV) - Market Insights, Epidemiology and Market Size Forecast-2020
2/1/2016 | published by: DelveInsight
... (France, Germany, Italy, Spain, UK) and ten Middle Eastern Countries (Jordan, Saudi Arabia, Kuwait, Oman, UAE, Tunisia, Turkey, Egypt, Lebanon and Qatar). It also includes global historical and forecasted epidemiological data for the diagnosed incident ...  |  read more...
USD 4,950
Acute Lung Injury - Pipeline Review, H2 2015
12/23/2015 | published by: Global Markets Direct
... information on the therapeutic development for Acute Lung Injury, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2015
12/31/2015 | published by: Global Markets Direct
... therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Chronic Obstructive Pulmonary Disease (COPD), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...  |  read more...
USD 2,000
2016 Emerging Opportunities in the Respiratory Syncytial Virus Diagnostic Testing Market (DataPack)
1/25/2016 | published by: VPGMarketResearch.com
... the Respiratory Syncytial Virus Diagnostic Testing Market. Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.  |  read more...
USD 2,800
Spain Respiratory Devices Market Outlook to 2021
11/2/2015 | published by: GlobalData
... of US dollars, volume (in units) and average price data (in US dollars), within market segments - Humidifiers, Oxygen Concentrators, Ventilators, Nebulizers, Positive Airway Pressure Devices, Reusable Resuscitators and Oxygen Conservers. The report also provides ...  |  read more...
USD 2,500
EpiCast Report: Pulmonary Arterial Hypertension - Epidemiology Forecast to 2024
1/1/2016 | published by: GlobalData
... in progressively increasing pulmonary vascular resistance, leading to an increase in pulmonary arterial pressure. The disease typically results in right-sided heart failure and premature death. PAH can be idiopathic, heritable, or associated with different conditions ...  |  read more...
USD 3,995
Chronic Obstructive Pulmonary Disease Pipeline Highlights – 2016
12/16/2015 | published by: Fore Pharma
... market. It covers emerging therapies for Chronic Obstructive Pulmonary Disease in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying ...  |  read more...
USD 680
Cystic Fibrosis Pipeline Highlights – 2016
12/16/2015 | published by: Fore Pharma
... Cystic Fibrosis in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 680
Pulmonary Edema Global Clinical Trials Review, H1, 2016
1/20/2016 | published by: GlobalData
... line data relating to the clinical trials on Pulmonary Edema. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical ...  |  read more...
USD 2,500
Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H2 2015
11/25/2015 | published by: Global Markets Direct
... therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Respiratory Syncytial Virus (RSV) Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...  |  read more...
USD 2,000
COPD Therapeutics in Major Developed Markets to 2021 - Emergence of Addition-in-Class and First-in-Class Products Offsets Sales Erosion of Leading Brands
11/13/2015 | published by: GBI Research
... inflammation of the airways and lungs. Persistent breathing difficulties and repeated exacerbations of COPD symptoms make the disease one of the leading causes of morbidity, and the fifth-leading cause of death in the world. COPD ...  |  read more...
USD 4,995
Global Cystic Fibrosis Drug Industry 2015 Market Research Report
11/25/2015 | published by: 9Dimen Research
... Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Cystic Fibrosis Drug basics: definitions, classifications, applications and industry chain overview; industry policies and plans; Product specifications; ...  |  read more...
USD 2,850
EpiCast Report: Chronic Obstructive Pulmonary Disease (COPD) - Epidemiology Forecast to 2023
12/1/2015 | published by: GlobalData
... of breath, wheezing, chest tightness, and other respiratory symptoms that progress over time. The disease is often caused by smoking; however, long-term exposure to other lung irritants, such as pollution, smoke from vehicle emissions and ...  |  read more...
USD 3,995
Pulmonary Hypertension - Pipeline Review, H2 2015
11/30/2015 | published by: Global Markets Direct
... therapeutic development for Pulmonary Hypertension, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Lung Infections Global Clinical Trials Review, H2, 2015
11/25/2015 | published by: GlobalData
... line data relating to the clinical trials on Lung Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical ...  |  read more...
USD 2,500
Chronic Respiratory Failure Global Clinical Trials Review, H2, 2015
11/25/2015 | published by: GlobalData
... report provides top line data relating to the clinical trials on Chronic Respiratory Failure. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers ...  |  read more...
USD 2,500
Viral Respiratory Tract Infection Global Clinical Trials Review, H2, 2015
11/25/2015 | published by: GlobalData
... trials scenario. This report provides top line data relating to the clinical trials on Viral Respiratory Tract Infection. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the ...  |  read more...
USD 2,500
Acute Respiratory Failure Global Clinical Trials Review, H2, 2015
11/25/2015 | published by: GlobalData
... report provides top line data relating to the clinical trials on Acute Respiratory Failure. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers ...  |  read more...
USD 2,500
Acute Lung Injury-Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA ...  |  read more...
USD 1,250
Bronchiolitis-Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. ...  |  read more...
USD 1,250
Chronic Bronchitis-Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
Chronic Thromboembolic Pulmonary Hypertension-Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent ...  |  read more...
USD 1,250
1    3    5  6  7  8  9  10